Covid -19, misinformation, and antimicrobial resistance
Well before covid-19, the world already faced an emergent threat of antimicrobial resistance, and many have sounded the alarm over further escalation during the pandemic. A study from the US, for example, showed that 71% of covid-19 patients received antibiotics while only 4% had true bacterial coinfection. This overuse of antibiotics may have contributed to the observed 10% increase in resistance against several classes of antibiotics (compared with 2019) at the same institution.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.